APA (7th ed.) Citation

E, K., S, A., B, P., M, H., Y, R., C, M., . . . A, V. (2026). Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01463-5

Chicago Style (17th ed.) Citation

E, Koo, et al. "Impact of Clinical Surveillance on Myeloma-related Complications in Patients with Precursor Plasma Cell Disorders." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01463-5.

MLA (9th ed.) Citation

E, Koo, et al. "Impact of Clinical Surveillance on Myeloma-related Complications in Patients with Precursor Plasma Cell Disorders." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01463-5.